BOUNDLESS BIO INC (BOLD) Forecast, Price Target & Analyst Ratings

NASDAQ:BOLD • US10170A1007

Current stock price

1.58 USD
-0.02 (-1.25%)
At close:
1.55 USD
-0.03 (-1.9%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BOUNDLESS BIO INC (BOLD).

Forecast Snapshot

Consensus Price Target

Price Target
$4.08
+ 158.23% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 7, 2026
Period
Q1 / 2026
EPS Estimate
-$0.59
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
45.71%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$4.08
Upside
+ 158.23%
From current price of $1.58 to mean target of $4.08, Based on 7 analyst forecasts
Low
$4.04
Median
$4.08
High
$4.20

Price Target Revisions

1 Month
33.33%
3 Months
33.33%

Price Target Summary

7 Wall Street analysts provided a forecast for the next 12 months for BOLD. The average price target is 4.08 USD. This implies a price increase of 158.23% is expected in the next year compared to the current price of 1.58.
The average price target has been revised upward by 33.33% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

BOLD Current Analyst RatingBOLD Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

BOLD Historical Analyst RatingsBOLD Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
45.71%
BOLD was analyzed by 7 analysts. The buy percentage consensus is at 46. So analysts seem to be rather neutral about BOLD.
In the previous month the buy percentage consensus was at a similar level.
BOLD was analyzed by 7 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-08-11HC Wainwright & Co.Maintains Buy -> Buy
2025-06-02HC Wainwright & Co.Initiate Buy
2025-05-28Leerink PartnersDowngrade Outperform -> Market Perform
2024-12-13GuggenheimDowngrade Buy -> Neutral
2024-04-22Leerink PartnersInitiate Outperform
2024-04-22GuggenheimInitiate Buy
2024-04-22Piper SandlerInitiate Overweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 7, 2026
Period
Q1 / 2026
EPS Estimate
-$0.59
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
17.15%
Number of Analysts
5

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
2.81%
EPS (3 Months)
-0.29%

Next Earnings Summary

BOLD is expected to report earnings on 5/7/2026. The consensus EPS estimate for the next earnings is -0.59 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2032

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
BOLD revenue by date.BOLD revenue by date.
N/AN/AN/AN/AN/A
21.65%		N/A
12.71%		N/A
9.77%
EBITDA
YoY % growth
BOLD ebitda by date.BOLD ebitda by date.
-24.619M-45.527M
-84.93%		-53.839M
-18.26%		-72.181M
-34.07%		-62.301M
13.69%		N/A
-5.24%		N/A
-5.62%		N/A
-25.07%		N/AN/AN/AN/A
EBIT
YoY % growth
BOLD ebit by date.BOLD ebit by date.
-25.301M-46.469M
-83.66%		-54.796M
-17.92%		-73.267M
-33.71%		-63.552M
13.26%		N/A
3.98%		N/A
-12.81%		N/A
-13.56%		N/A
73.90%		N/A
205.00%		N/A
180.95%		N/A
52.54%
Operating Margin
BOLD operating margin by date.BOLD operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
BOLD eps by date.BOLD eps by date.
N/AN/AN/A-14.52-2.61
82.02%		N/A
6.34%		N/A
46.45%		N/A
12.73%		N/AN/AN/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.59
17.15%		-0.62
12.09%		-0.65
-4.74%		-0.59
-2.00%		-0.70
-19.65%		-0.71
-16.02%		-0.38
41.89%		-0.37
37.93%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		-14.849M
12.78%		-16.016M
2.50%		-17.127M
-20.58%		-17.572M
-37.81%		N/AN/AN/AN/A
EBIT
Q2Q % growth		-14.269M
17.72%		-14.928M
12.50%		-15.704M
-3.67%		-16.12M
-15.13%		N/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

BOLD Yearly Revenue VS EstimatesBOLD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2029 2030 2031 2032 50M 100M 150M 200M 250M
BOLD Yearly EPS VS EstimatesBOLD Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 -5 -10

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
16.03%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-10.97%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

BOUNDLESS BIO INC / BOLD Forecast FAQ

Can you provide the average price target for BOUNDLESS BIO INC stock?

7 analysts have analysed BOLD and the average price target is 4.08 USD. This implies a price increase of 158.23% is expected in the next year compared to the current price of 1.58.

When does BOUNDLESS BIO INC (BOLD) report earnings?

BOUNDLESS BIO INC (BOLD) will report earnings on 2026-05-07.

What are the consensus estimates for BOUNDLESS BIO INC (BOLD) next earnings?

The consensus EPS estimate for the next earnings of BOUNDLESS BIO INC (BOLD) is -0.59 USD and the consensus revenue estimate is 0 USD.